Tracleer and Fluid retention - a phase IV clinical study of FDA data
Summary:
Fluid retention is reported as a side effect among people who take Tracleer (bosentan), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Coumadin, and have Pulmonary hypertension.
The phase IV clinical study analyzes which people have Fluid retention when taking Tracleer. It is created by eHealthMe based on reports of 55,065 people who have side effects when taking Tracleer from the FDA, and is updated regularly.
What is Tracleer?
Tracleer has active ingredients of bosentan. It is often used in primary pulmonary hypertension. eHealthMe is studying from 55,125 Tracleer users. Check the latest studies of Tracleer.
What is Fluid retention?
Fluid retention (an abnormal accumulation of fluid in the blood) is found to be associated with 1,699 drugs and 2,448 conditions by eHealthMe. Check the latest studies of Fluid retention.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
55,065 people reported to have side effects when taking Tracleer.
Among them, 1,849 people (3.36%) have Fluid retention.

Among these 1,849 people:
How long have people been on Tracleer when they have Fluid retention? *
What is the gender of people who have Fluid retention when taking Tracleer? *
What is the age of people who have Fluid retention when taking Tracleer? *
What are other drugs people take besides Tracleer? *
What are other side effects people have besides Fluid retention? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Tracleer and have Fluid retention?
- Check whether Fluid retention is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Tracleer:
- Tracleer (55,125 reports)
Fluid retention treatments and more:
- Fluid retention (79,660 reports)
How severe was Fluid retention and when was it recovered:
Expand to all the drugs that have ingredients of bosentan:
- Fluid retention and drugs with ingredients of bosentan (2,041 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Tracleer:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Fluid retention:
- Fluid retention (1,699 drugs)
Browse all the conditions that are associated with Fluid retention:
- Fluid retention (2,448 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on bosentan (the active ingredients of Tracleer) and Tracleer (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Latuda and Tardive Dyskinesia for Women aged 20-29 - 2 seconds ago
- Jaundice - Yellow Skin and drugs of ingredients of gemcitabine hydrochloride - 3 seconds ago
- Cognitive Disorder and drugs of ingredients of efavirenz - 4 seconds ago
- Cough and drugs of ingredients of tobramycin sulfate - 8 seconds ago
- Gastroenteritis and drugs of ingredients of dicyclomine hydrochloride - 9 seconds ago
- Grand Mal Convulsion and drugs of ingredients of amoxicillin - 10 seconds ago
- Drug interactions of Klonopin and Meprobamate - 12 seconds ago
- Solu-Medrol and Hypercalcaemia Aggravated for Men aged 60+ - 14 seconds ago
- Blopress vs. Metolazone, side effect and effectiveness comparison - 14 seconds ago
- Hot Flush and drugs of ingredients of orphenadrine citrate - 16 seconds ago